Elutia Inc. (ELUT)
NASDAQ: ELUT · IEX Real-Time Price · USD
+0.090 (2.80%)
May 17, 2024, 4:00 PM EDT - Market closed

Elutia Revenue

Elutia had revenue of $28.99M in the twelve months ending March 31, 2024, down -7.86% year-over-year. Revenue in the quarter ending March 31, 2024 was $6.69M with 4.72% year-over-year growth. In the year 2023, Elutia had annual revenue of $24.75M with 3.76% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
92.79M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 202324.75M896.00K3.76%
Dec 31, 202223.85M-23.54M-49.68%
Dec 31, 202147.39M4.71M11.03%
Dec 31, 202042.68M-219.00K-0.51%
Dec 31, 201942.90M3.86M9.90%
Dec 31, 201839.04M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Xtant Medical Holdings 101.23M
Eton Pharmaceuticals 35.30M
BrainsWay 34.26M
Oramed Pharmaceuticals 674.00K
Barinthus Biotherapeutics 334.00K
Revenue Rankings